These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27450363)

  • 1. Pramipexole Responsive Neck Numbness: The Therapeutic Role of Dopamine Agonists in the Spinal Cord Indicating to a Common Spinal Pathophysiology with Restless Leg Syndrome (RLS)?
    Yulug B; Hanoglu L
    Curr Clin Pharmacol; 2016; 11(3):221-222. PubMed ID: 27450363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More Evidence for the Therapeutic Role of Pramipexole in Upper Limb Restlessness Due to Cervical Disc Pathology?
    Yulug B; Hanoglu L; Brandmeier S
    Curr Clin Pharmacol; 2018; 13(1):73-74. PubMed ID: 29493461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restless legs syndrome: differential diagnosis and management with pramipexole.
    Brindani F; Vitetta F; Gemignani F
    Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pramipexole for the treatment of restless legs syndrome.
    Kushida CA
    Expert Opin Pharmacother; 2006 Mar; 7(4):441-51. PubMed ID: 16503816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic dopaminergic treatment in restless legs syndrome: does it affect the autonomic nervous system?
    Rocchi C; Albanese M; Placidi F; Romigi A; Lauretti B; Marfia GA; Liguori C; Marciani MG; Mercuri NB; Izzi F
    Sleep Med; 2015 Sep; 16(9):1071-6. PubMed ID: 26298781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model.
    Luo F; Li C; Ondo WG; Xu P; Xie W; Le W
    Sleep Med; 2011 Jan; 12(1):41-6. PubMed ID: 21044864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood.
    Montagna P; Hornyak M; Ulfberg J; Hong SB; Koester J; Crespi G; Albrecht S
    Sleep Med; 2011 Jan; 12(1):34-40. PubMed ID: 20965780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
    Garcia-Borreguero D; Patrick J; DuBrava S; Becker PM; Lankford A; Chen C; Miceli J; Knapp L; Allen RP
    Sleep; 2014 Apr; 37(4):635-43. PubMed ID: 24899755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pramipexole: in restless legs syndrome.
    McCormack PL; Siddiqui MA
    CNS Drugs; 2007; 21(5):429-37; discussion 438-40. PubMed ID: 17447832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Pramipexole for the Treatment of Primary Restless Leg Syndrome: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
    Liu GJ; Wu L; Lin Wang S; Xu LL; Ying Chang L; Fu Wang Y
    Clin Ther; 2016 Jan; 38(1):162-179.e6. PubMed ID: 26572941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pramipexole in the treatment of restless legs syndrome: a follow-up study.
    Montplaisir J; Denesle R; Petit D
    Eur J Neurol; 2000 May; 7 Suppl 1():27-31. PubMed ID: 11054156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacies of oral iron and pramipexole for the treatment of restless legs syndrome patients with low serum ferritin.
    Lee CS; Lee SD; Kang SH; Park HY; Yoon IY
    Eur J Neurol; 2014 Feb; 21(2):260-6. PubMed ID: 24267148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential D2 or preferential D3 dopamine agonists in restless legs syndrome.
    Manconi M; Ferri R; Zucconi M; Clemens S; Giarolli L; Bottasini V; Ferini-Strambi L
    Neurology; 2011 Jul; 77(2):110-7. PubMed ID: 21715702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and the spinal cord in restless legs syndrome: does spinal cord physiology reveal a basis for augmentation?
    Paulus W; Schomburg ED
    Sleep Med Rev; 2006 Jun; 10(3):185-96. PubMed ID: 16762808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postural control in restless legs syndrome with medication intervention using pramipexole.
    Ahlgrén-Rimpiläinen A; Lauerma H; Kähkönen S; Aalto H; Tuisku K; Holi M; Pyykkö I; Rimpiläinen I
    Neurol Sci; 2014 Feb; 35(2):199-204. PubMed ID: 23794113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment options for restless legs syndrome.
    Ferini-Strambi L
    Expert Opin Pharmacother; 2009 Mar; 10(4):545-54. PubMed ID: 19284359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of exercise and pramipexole in the treatment of restless leg syndrome: Implications on the dopaminergic system and PTPRD.
    Morais MA; Franco B; Holanda ASS; Simino LAP; Manconi M; Torsoni A; Esteves AM
    Sleep Med; 2023 Oct; 110():201-211. PubMed ID: 37633178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS.
    Varga LI; Ako-Agugua N; Colasante J; Hertweck L; Houser T; Smith J; Watty AA; Nagar S; Raffa RB
    J Clin Pharm Ther; 2009 Oct; 34(5):493-505. PubMed ID: 19744006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of pregabalin with pramipexole for restless legs syndrome.
    Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
    N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restless leg syndrome in patients with spinal cord injury.
    Kumru H; Vidal J; Benito J; Barrio M; Portell E; Valles M; Flores C; Santamaria J
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1461-4. PubMed ID: 26476461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.